Your Gut Is Quietly Deciding How Well You Remember Things

Right now, somewhere along your vagus nerve, signals are travelling from your intestine to your hippocampus. They have been doing this your whole life, in the background, largely ignored by neuroscience. Whether those signals stay strong into old age, it now appears, may be one of the most consequential factors in whether you keep your memory sharp or begin to lose it in your 50s or 60s. And the thing that determines whether those signals stay strong? The bacteria living in your gut.

That, in rough outline, is the conclusion of a paper published today in Nature by researchers at Stanford Medicine and the Arc Institute in Palo Alto. It’s a finding that forces a fairly uncomfortable revision of how we think about memory decline, which most people, including most researchers, have long assumed to be primarily a brain problem.

The reasoning behind that assumption is obvious enough. Memory lives in the hippocampus. Hippocampal function degrades with age. So you go looking for the cause in the hippocampus. What Christoph Thaiss and his colleagues found instead is that the degradation doesn’t necessarily start there. “The timeline of memory decline is not hardwired,” Thaiss said; “it’s actively modulated in the body, and the gastrointestinal tract is a critical regulator of this process.”

The key experiment was, on its face, slightly peculiar: the team housed young mice (two months old) with old mice (eighteen months old). Living in close quarters, sharing bedding, sharing the microbial community that accumulates in a cage, the young mice gradually acquired gut microbiomes that resembled their elderly cagemates. Within a month, those young mice were performing like old animals on cognitive tests: failing to show curiosity about novel objects, blundering through mazes they would normally navigate with ease. Their brains were young. Their guts, microbiologically speaking, were not.

Control experiments ruled out the obvious confounds. Co-housing young mice with other young mice produced no cognitive effect. Mice raised from birth in germ-free conditions, with no gut bacteria at all, showed no age-related memory decline even at eighteen months. When the researchers transplanted faecal microbiomes from old donors into young germ-free recipients, the recipients developed the cognitive profile of old animals. And when they wiped out the gut bacteria of young mice with a course of broad-spectrum antibiotics after cognitive decline had set in, memory recovered. Fully. Two weeks of antibiotics, and the animals were back to normal.

The implications of that reversal are hard to overstate. “The degree of reversibility of age-related cognitive decline in the animals just by altering gut-brain communication was a surprise,” Thaiss said. “We tend to think of memory decline as a brain-intrinsic process.” He described what followed from the finding as “a kind of remote control for the brain.”

Getting from gut bacteria to memory loss requires a pathway, and the team traced it step by step. As mice age, the relative abundance of a bacterium called Parabacteroides goldsteinii increases in the gut. This species produces medium-chain fatty acids, including a compound called 3-hydroxyoctanoic acid. Those fatty acids bind to a receptor called GPR84 on immune cells called myeloid cells in the gut wall. The myeloid cells, stimulated, produce inflammatory cytokines, specifically TNF and interleukin-1 beta. Those cytokines don’t travel to the brain. Instead, they impair the local function of the vagus nerve, the long cable of sensory fibres running from the gut to the brainstem. With vagal activity suppressed, the hippocampus receives weaker interoceptive signals. And with those signals weakened, it encodes memories less effectively. “Basically,” Thaiss said, “we’ve identified a three-step pathway toward cognitive decline that starts with gastrointestinal aging and the subsequent microbial and metabolic changes that occur. The myeloid cells in the GI tract sense these changes, and their inflammatory response impairs the connection between the gut and the brain via the vagus nerve. This is a direct driver of memory decline.”

There is something strange and perhaps slightly vertiginous about this account. The brain, you’d think, should be the thing that processes information about the world, including information about its own status. But Thaiss’s framing draws on a distinction that most of us haven’t consciously encountered: interoception versus exteroception. Exteroception is your five senses, your perception of what’s outside you. Interoception is your brain’s perception of what’s inside you, the signals from your organs, your gut, your heart. “We have a lot of detailed knowledge about how [exteroception] works,” Thaiss said, “but we know much less about how the brain senses what is going on inside the body.” His study suggests that as we age, our interoceptive capacity declines just as our eyesight or hearing does; only nobody is fitting people with reading glasses for their vagus nerve.

Maayan Levy, the other senior author, frames the finding in evolutionary terms. “The GI tract is arguably the first organ system to evolve during human evolutionary history,” she said, “so the evolution of cognitive processes in the brain has undoubtedly been shaped by signals coming from the intestine.” From that perspective, a gut-brain communication pathway for memory isn’t so surprising. What’s surprising is that it had gone largely uncharacterised until now.

The researchers also identified several ways to intervene. Stimulating vagal activity in old mice, using a pharmacological agonist, restored their memory performance to that of young animals. GPR84 inhibitors blocked the inflammatory cascade triggered by the medium-chain fatty acids. Bacteriophages targeting Parabacteroides reduced the bacterial population producing those fatty acids in the first place. And GLP-1 receptor agonists, the same class of drugs now widely used for diabetes and obesity, also restored memory function by activating vagal afferents, though the researchers are careful to note the mechanistic distance between a mouse study and a clinical trial.

What the paper does not yet do is establish whether this pathway operates in humans. The anatomy is conserved, the vagus nerve carries similar signals, ageing gut microbiomes in people show comparable shifts in bacterial populations. But the specific findings come from mice, and the specific bacterium implicated, Parabacteroides goldsteinii, may not be the culprit in human populations. The team are now investigating whether analogous changes occur in people and whether they correlate with cognitive performance. Given that vagus nerve stimulation is already FDA-approved for depression and epilepsy, there may be a shorter path to human application than usual, if the mechanism holds.

“Our hope is that ultimately these findings can be translated into the clinic to combat age-related cognitive decline in people,” Thaiss said. That remains a hope rather than a plan. But the conceptual shift is already complete: what’s happening in your gut, at this moment, may be doing something about what you remember tomorrow.

DOI: https://doi.org/10.1038/s41586-026-10191-6

Frequently Asked Questions

Related